is a Ontology.
The Pistoia Alliance Pharma General Ontology (PGO) is a collaborative initiative to provide a shared upper-level reference ontology for the pharmaceutical industry. PGO aims to serve as a "Rosetta Stone" enabling semantic interoperability within and across organizations by identifying key concepts used throughout the drug development lifecycle and selecting public resources that can provide identifiers for each concept. Rather than creating new ontologies or mandating specific terminologies, PGO focuses on providing clear mechanisms to enable unambiguous declaration of the resources used and capturing the criteria for selecting semantic artifacts. The project follows FAIR principles and reuses existing semantic resources, including ontologies and controlled terminologies, as well as open source community software. The initial phase focuses on Research & Development (R&D) operations, defining core concepts and recommendations for associating controlled terminologies to service data exchange among pharmaceutical industry stakeholders. PGO is developed using LinkML for representing and documenting each type, and is supported by a consortium of major pharmaceutical companies including AstraZeneca, Chiesi Group, GSK, Merck KGaA, Novo Nordisk, Pfizer, and Hoffmann-La Roche.
Giovanni Nisato
Github: Giovanni-Nisato
Philippe Rocca-Serra
Github: proccaserra
| ID | Name | URL | Category | Format | Description |
|---|---|---|---|---|---|
| pistoia-pgo.github | PGO GitHub Repository | Pistoia-Alliance-PGO | Ontology | http | GitHub repository containing the PGO ... |
| pistoia-pgo.documentation | PGO Documentation Website | Pistoia-Alliance-PGO | Documentation | http | Documentation website for PGO includi... |
| pistoia-pgo.core_concepts | PGO Core Concepts (Version 1.0) | 2025_PGO_V1.0_core_concepts.md (16.2 KB) | Documentation | txt | Markdown list of the PGO Version 1.0 ... |
| pistoia-pgo.core_concepts_csv | PGO Core Concepts CSV (Version 1.0) | PGO_V1.0_core_concepts_2026-03-20.csv (11.0 KB) | Product | csv | CSV release of the PGO Version 1.0 co... |
| pistoia-pgo.core_concepts_xlsx | PGO Core Concepts Excel (Version 1.0) | PGO_V1.0_core_concepts_2026-03-20.xlsx (22.8 KB) | Product | xlsx | Excel release of the PGO Version 1.0 ... |
| pistoia-pgo.use_cases | PGO Use Cases | pharma-general-ontology-use-cases | Documentation | http | High-level use cases demonstrating PG... |
| pistoia-pgo.project_page | PGO Project Page | pharma-general-ontology | Documentation | http | Pistoia Alliance project page for PGO... |
The Pistoia Alliance Pharma General Ontology (PGO), also called PGO-Terminology, is a collaborative Pistoia Alliance project to agree on a shared set of core concepts for pharmaceutical research and development and to recommend public vocabularies that can supply identifiers for each concept.
PGO addresses the insufficient and ambiguous asset descriptions that hamper information exchange within and across pharmaceutical organizations. Rather than mandating one resource over another, PGO aims to make it clear which controlled terminologies are used and why. Phase 1 started in April 2024 and focused on research and early development (R&ED).
The Version 1.0 core concept list contains 17 concepts: Assay, Biomarker, Biospecimen, Cell, Clinical study, Clinical study site, Compound, Device, Disease, Drug, Gene, Indication, Pharmaceutical product, Protein, Species, Substance, and Unit. Each concept has a recommended definition reused from an existing resource, mostly the NCI Thesaurus, with others taken from OBI, MeSH, ChEBI, PSI-MI, UniProt, and QUDT, along with the date the PGO steering committee approved it and examples of candidate sources.
Phase 1 (2024-2025):
Phase 2 (2025-2026):
Phase 1 sponsors listed in the repository are AstraZeneca, Chiesi Group, GSK, Merck KGaA, Novo Nordisk, Pfizer, and Roche. The Pistoia Alliance project page also lists Vertex as a supporter.
This resource was manually curated for the Knowledge Graph Registry.
Created: November 10, 2025 | Last modified: November 10, 2026